ReWalk Robotics Ltd (NASDAQ:RWLK) Position Decreased by Highbridge Capital Management LLC
Highbridge Capital Management LLC reduced its position in shares of ReWalk Robotics Ltd (NASDAQ:RWLK) by 80.0% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 100,000 shares of the medical device company’s stock after selling 400,000 shares during the period. Highbridge Capital Management LLC owned 0.60% of ReWalk Robotics worth $210,000 as of its most recent filing with the SEC.
Separately, Renaissance Technologies LLC increased its position in shares of ReWalk Robotics by 171.5% in the fourth quarter. Renaissance Technologies LLC now owns 48,600 shares of the medical device company’s stock valued at $136,000 after buying an additional 30,700 shares during the last quarter. 4.69% of the stock is currently owned by institutional investors and hedge funds.
Shares of ReWalk Robotics Ltd (RWLK) remained flat at $1.45 during mid-day trading on Tuesday. 170,213 shares of the stock traded hands. The company has a 50-day moving average of $1.61 and a 200 day moving average of $1.76. The stock’s market capitalization is $24.18 million. ReWalk Robotics Ltd has a 12 month low of $1.10 and a 12 month high of $7.25.
ReWalk Robotics (NASDAQ:RWLK) last announced its quarterly earnings data on Thursday, August 3rd. The medical device company reported ($0.29) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.35) by $0.06. The firm had revenue of $2.01 million during the quarter, compared to analyst estimates of $1.71 million. ReWalk Robotics had a negative return on equity of 528.26% and a negative net margin of 389.13%. The company’s revenue was up 145.7% on a year-over-year basis. During the same period last year, the company earned ($0.64) earnings per share. On average, equities analysts forecast that ReWalk Robotics Ltd will post ($1.30) EPS for the current year.
RWLK has been the topic of several research reports. Canaccord Genuity reissued a “buy” rating on shares of ReWalk Robotics in a research report on Monday, June 12th. Zacks Investment Research raised shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $1.50 price objective on the stock in a research report on Thursday, May 11th. Finally, Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $4.00 price objective (down from $7.00) on shares of ReWalk Robotics in a research report on Wednesday, May 10th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average target price of $4.00.
In other news, Director Jeff Dykan sold 37,030 shares of the business’s stock in a transaction dated Monday, June 26th. The stock was sold at an average price of $3.00, for a total transaction of $111,090.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Wayne Weisman sold 87,000 shares of the business’s stock in a transaction dated Tuesday, June 27th. The stock was sold at an average price of $3.05, for a total value of $265,350.00. The disclosure for this sale can be found here. Insiders have sold a total of 199,883 shares of company stock valued at $604,772 over the last 90 days. Corporate insiders own 13.70% of the company’s stock.
ReWalk Robotics Company Profile
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.
Receive News & Stock Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related stocks with our FREE daily email newsletter.